AI assistant
Sending…
REGENXBIO Inc. — Director's Dealing 2017
Mar 29, 2017
32827_dirs_2017-03-29_2e697179-0523-4da3-aaad-0bb921ed8c02.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: REGENXBIO Inc. (RGNX)
CIK: 0001590877
Period of Report: 2017-03-27
Reporting Person: Danos Olivier (Chief Scientific Officer)
More from REGENXBIO Inc.
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Proxy Solicitation & Information Statement
2026
Apr 14
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Feb 10
Director's Dealing
2026
Feb 3
Director's Dealing
2026
Feb 3
Director's Dealing
2026
Jan 29
Regulatory Filings
2026
Jan 28
Major Shareholding Notification
2026
Jan 21